RBC Capital Markets advice for Pharming
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| March 29, 2023 | RBC Capital Markets | Pharming | Buy | 1.80 EUR | 41.67 % |
Advice details
Toronto - Op 29 maa (her)starten de analisten van RBC Capital Markets met het volgen van het Nederlandse farmaceutisch concern Pharming (ISIN: NL0010391025 / Mnemo: PHARM) met een koopadvies. Het 12-maands koersdoel is vastgesteld op 1.8 EUR
Last RBC Capital Markets advice for Pharming
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| March 29, 2023 | RBC Capital Markets | Pharming | Buy | 1.80 EUR | 41.67 % |
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2024 ValueSpectrum. All Rights Reserved
Developed and maintained by 